Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Cancer-associated fibroblasts induce metalloprotease-independent cancer cell invasion of the basement membrane.

Glentis A, Oertle P, Mariani P, Chikina A, El Marjou F, Attieh Y, Zaccarini F, Lae M, Loew D, Dingli F, Sirven P, Schoumacher M, Gurchenkov BG, Plodinec M, Vignjevic DM.

Nat Commun. 2017 Oct 13;8(1):924. doi: 10.1038/s41467-017-00985-8.

2.

The Role of Fibroblasts in Pancreatic Cancer: Extracellular Matrix Versus Paracrine Factors.

Bolm L, Cigolla S, Wittel UA, Hopt UT, Keck T, Rades D, Bronsert P, Wellner UF.

Transl Oncol. 2017 Aug;10(4):578-588. doi: 10.1016/j.tranon.2017.04.009. Epub 2017 Jun 26.

3.

Dual Targeting of Mesenchymal and Amoeboid Motility Hinders Metastatic Behavior.

Jones BC, Kelley LC, Loskutov YV, Marinak KM, Kozyreva VK, Smolkin MB, Pugacheva EN.

Mol Cancer Res. 2017 Jun;15(6):670-682. doi: 10.1158/1541-7786.MCR-16-0411. Epub 2017 Feb 24.

PMID:
28235899
4.

Fibronectin Extra Domain A Promotes Liver Sinusoid Repair following Hepatectomy.

Sackey-Aboagye B, Olsen AL, Mukherjee SM, Ventriglia A, Yokosaki Y, Greenbaum LE, Lee GY, Naga H, Wells RG.

PLoS One. 2016 Oct 14;11(10):e0163737. doi: 10.1371/journal.pone.0163737. eCollection 2016.

5.

A Chemomechanical Model of Matrix and Nuclear Rigidity Regulation of Focal Adhesion Size.

Cao X, Lin Y, Driscoll TP, Franco-Barraza J, Cukierman E, Mauck RL, Shenoy VB.

Biophys J. 2015 Nov 3;109(9):1807-17. doi: 10.1016/j.bpj.2015.08.048.

6.

Obesity-dependent changes in interstitial ECM mechanics promote breast tumorigenesis.

Seo BR, Bhardwaj P, Choi S, Gonzalez J, Andresen Eguiluz RC, Wang K, Mohanan S, Morris PG, Du B, Zhou XK, Vahdat LT, Verma A, Elemento O, Hudis CA, Williams RM, Gourdon D, Dannenberg AJ, Fischbach C.

Sci Transl Med. 2015 Aug 19;7(301):301ra130. doi: 10.1126/scitranslmed.3010467.

7.

Stromal androgen receptor regulates the composition of the microenvironment to influence prostate cancer outcome.

Leach DA, Need EF, Toivanen R, Trotta AP, Palethorpe HM, Tamblyn DJ, Kopsaftis T, England GM, Smith E, Drew PA, Pinnock CB, Lee P, Holst J, Risbridger GP, Chopra S, DeFranco DB, Taylor RA, Buchanan G.

Oncotarget. 2015 Jun 30;6(18):16135-50. Erratum in: Oncotarget. 2015 Nov 3;6(34):36923. Palenthorpe, Helen M [Corrected to Palethorpe, Helen M].

8.

Stiffening and unfolding of early deposited-fibronectin increase proangiogenic factor secretion by breast cancer-associated stromal cells.

Wang K, Andresen Eguiluz RC, Wu F, Seo BR, Fischbach C, Gourdon D.

Biomaterials. 2015 Jun;54:63-71. doi: 10.1016/j.biomaterials.2015.03.019. Epub 2015 Mar 29.

9.

Fibroblast-induced matrix remodeling paves the path for invasion.

Van Bockstal M, Libbrecht L, De Wever O.

Cell Cycle. 2015;14(6):793-4. doi: 10.1080/15384101.2015.1010968. No abstract available.

10.

Differential regulation of extracellular matrix protein expression in carcinoma-associated fibroblasts by TGF-β1 regulates cancer cell spreading but not adhesion.

Van Bockstal M, Lambein K, Van Gele M, De Vlieghere E, Limame R, Braems G, Van den Broecke R, Cocquyt V, Denys H, Bracke M, Libbrecht L, De Wever O.

Oncoscience. 2014 Oct 15;1(10):634-48. eCollection 2014.

11.

Caveolin-1 deficiency induces a MEK-ERK1/2-Snail-1-dependent epithelial-mesenchymal transition and fibrosis during peritoneal dialysis.

Strippoli R, Loureiro J, Moreno V, Benedicto I, Pérez Lozano ML, Barreiro O, Pellinen T, Minguet S, Foronda M, Osteso MT, Calvo E, Vázquez J, López Cabrera M, del Pozo MA.

EMBO Mol Med. 2015 Jan;7(1):102-23. doi: 10.15252/emmm.201404127. Erratum in: EMBO Mol Med. 2015 Mar;7(3):357.

12.

Cellular localization, invasion, and turnover are differently influenced by healthy and tumor-derived extracellular matrix.

Genovese L, Zawada L, Tosoni A, Ferri A, Zerbi P, Allevi R, Nebuloni M, Alfano M.

Tissue Eng Part A. 2014 Jul;20(13-14):2005-18. doi: 10.1089/ten.TEA.2013.0588. Epub 2014 Mar 6.

13.

Effective inhibition of c-MET-mediated signaling, growth and migration of ovarian cancer cells is influenced by the ovarian tissue microenvironment.

Kwon Y, Smith BD, Zhou Y, Kaufman MD, Godwin AK.

Oncogene. 2015 Jan 8;34(2):144-53. doi: 10.1038/onc.2013.539. Epub 2013 Dec 23.

14.

Miniaturized pre-clinical cancer models as research and diagnostic tools.

Håkanson M, Cukierman E, Charnley M.

Adv Drug Deliv Rev. 2014 Apr;69-70:52-66. doi: 10.1016/j.addr.2013.11.010. Epub 2013 Dec 1. Review.

15.

Enhancement of head and neck squamous cell carcinoma proliferation, invasion, and metastasis by tumor-associated fibroblasts in preclinical models.

Wheeler SE, Shi H, Lin F, Dasari S, Bednash J, Thorne S, Watkins S, Joshi R, Thomas SM.

Head Neck. 2014 Mar;36(3):385-92. doi: 10.1002/hed.23312. Epub 2013 Jun 1.

16.

Loss of SPARC in bladder cancer enhances carcinogenesis and progression.

Said N, Frierson HF, Sanchez-Carbayo M, Brekken RA, Theodorescu D.

J Clin Invest. 2013 Feb;123(2):751-66. doi: 10.1172/JCI64782. Epub 2013 Jan 16. Erratum in: J Clin Invest. 2013 Sep 3;123(9):4089.

17.

The mesenchymal tumor microenvironment: a drug-resistant niche.

Cukierman E, Bassi DE.

Cell Adh Migr. 2012 May-Jun;6(3):285-96. doi: 10.4161/cam.20210. Epub 2012 May 1. Review.

18.

Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma.

Gupta V, Bassi DE, Simons JD, Devarajan K, Al-Saleem T, Uzzo RG, Cukierman E.

PLoS One. 2011;6(6):e21494. doi: 10.1371/journal.pone.0021494. Epub 2011 Jun 28.

19.

Carcinoma matrix controls resistance to cisplatin through talin regulation of NF-kB.

Eberle KE, Sansing HA, Szaniszlo P, Resto VA, Berrier AL.

PLoS One. 2011;6(6):e21496. doi: 10.1371/journal.pone.0021496. Epub 2011 Jun 24.

20.

FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells.

Lee HO, Mullins SR, Franco-Barraza J, Valianou M, Cukierman E, Cheng JD.

BMC Cancer. 2011 Jun 13;11:245. doi: 10.1186/1471-2407-11-245.

Supplemental Content

Support Center